TwinBeech Capital’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

TwinBeech Capital’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-72,733	Closed	-$1.36M	–	785
2022 Q1	$1.36M	Buy	+72,733	New	+$1.31M	0.06%	281
2021 Q4	–	Sell	-31,099	Closed	-$575K	–	888
2021 Q3	$575K	Buy	+31,099	New	+$626K	0.04%	418

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TwinBeech Capital's OCDX Position: Q2 2022 in Review

TwinBeech Capital sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 72,733 shares — an estimated $1.36M sold.

TwinBeech Capital first reported a position in OCDX in Q3 2021 and held it in 2 quarters. The position peaked at $1.36M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

TwinBeech Capital reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
TwinBeech Capital sold 72,733 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $1.36M.
TwinBeech Capital first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q3 2021 and held it in 2 quarters.
TwinBeech Capital's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.36M in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on TwinBeech Capital's 13F filing for Q2 2022, filed 15 Aug 2022.